NCT07164612Not yet recruiting
The Effectiveness of Occupation-based Bilateral Arm Training on Motor Functions and Activity Participation Among Stroke Survivors During Inpatient Rehabilitation.
The Effectiveness of Occupation-based Bilateral Arm Training on Motor Functions and Activity Participation Among Stroke Survivors During Inpatient Rehabilitation. A Randomized Control Trial
Source: ClinicalTrials.gov · Last updated 22 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
People with stroke often experience limitations in motor functions and activity participation. Occupation-based bilateral upper limb training (OBBT) using occupations as meaningful daily activities, and as part of the therapy. The activities in OBBT are tailored to the patient's life with the goal of boosting motivation and engagement to enhance activity performance and participation. This study is a randomized control trial that aims to explore the effect of OBBT along with the conventional therapy in comparison with the conventional therapy alone on motor functions and activity participation among stroke survivors in inpatient rehabilitation setting. This study will be conducted in Qatar Rehabilitation Institute, Hamad Medical Corporation, Doha, Qatar. Participants will be allocated randomly to either the OBBT group or the conventional therapy group. Participants in the OBBT group will receive 30 minutes OBBT program in addition to conventional therapy (90 minutes). Intervention sessions will be conducted 5 times per week over 6 weeks. The participants in the conventional therapy group will receive only the conventional therapy (90 minute). All participants will be assessed using the outcome measure immediately the day after completing the last intervention session at 4th week and 6th week.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 2 Sept 2025
- Start date
- Sept 2025
- Primary completion date
- Apr 2027
- Lead sponsor
- Hamad Medical Corporation
- Diseases
- Stroke
- NCT number
- NCT07164612
What you commit to
- Study type: Interventional
- Planned participants: 150
- From Sept 2025 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- participants with previous stroke
Other illness
- musculoskeletal disease or sever pain affecting the upper extremities
Other
- participant who have taken part in another rehabilitative research
- sever visual neglect or visual field deficit.
Who the study is looking for
- Diagnosed with first ischemic or hemorrhagic stroke by medical physician
- Stroke onset ≤ 6 months
- Both males and females with age 18-65 years
- Cognitive functions within normal and mild deficit (MMSE ≥ 22)
- With arm and hand upper extremity Brunnstrom stage of \>3
- Free of any other neurological diseases.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hamad Medical Corporation\ Qatar Rehabilitation Institute Coordinator of this site? Confirm its status | Doha | Qatar | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.